The Lancet Haematology Home Page
eClinicalMedicine Home Page
Pathophysiology, prevention, and treatment of medication overuse headache - The Lancet Neurology
Cognitive outcomes at age 3 years in children with fetal exposure to antiseizure medications (MONEAD study) in the USA: a prospective, observational cohort study - The Lancet Neurology
Drug harms in the UK: a multicriteria decision analysis - The Lancet
Inequalities in the use of secondary prevention of cardiovascular disease by socioeconomic status: evidence from the PURE observational study - The Lancet Global Health
Hard Shell Diabetes Testing Kit Case Diabetic Supply Travel Bag Organizer for Glucose Meter, Blood Sugar Test Strips, Lancets, Lancet Device, Pen Needles, Syringes, Alcohol Swabs, Medication (Black) : Buy Online at
Racial/ethnic and socioeconomic disparities in the use of newer diabetes medications in the Look AHEAD study - The Lancet Regional Health – Americas
Covid-19: Lancet retracts paper that halted hydroxychloroquine trials | Coronavirus | The Guardian
Antihypertensive medications and risk for incident dementia and Alzheimer's disease: a meta-analysis of individual participant data from prospective cohort studies - The Lancet Neurology
Antipsychotic drug effective and safe in paranoid older people who usually aren't treated | UCL News - UCL – University College London
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study - The Lancet
The Lancet Psychiatry, January 2024, Volume 11, Issue 1, Pages 1-80, e1-e3
Voglibose for prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japanese individuals with impaired glucose tolerance - The Lancet
Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial - The Lancet Neurology
Implementation of a mobile health clinic framework for Hepatitis C virus screening and treatment: a descriptive study - The Lancet Regional Health – Americas
Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis - The Lancet
Initiation of pharmacological therapy in Parkinson's disease: when, why, and how - The Lancet Neurology
How the structural determinants of health inequities impact access to prescription medication for pregnant women in Australia: a narrative review - The Lancet Regional Health – Western Pacific
eClinicalMedicine Home Page
The Lancet - The Lancet Oncology | Series | Drug safety in oncology Read the Series: https://hubs.ly/H0bvBYw0 Given the success of The Lancet Oncology's last series on drug safety in oncology in
Maintenance therapy after quadruple induction therapy in HIV-1 infected individuals: Amsterdam Duration of Antiretroviral Medication (ADAM) study - The Lancet
Immunogenicity, safety, and tolerability of a recombinant measles-vectored Lassa fever vaccine: a randomised, placebo-controlled, first-in-human trial - The Lancet
Targeting the biology of ageing with mTOR inhibitors to improve immune function in older adults: phase 2b and phase 3 randomised trials - The Lancet Healthy Longevity
